mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process

Sulaiman K Marafie1, Fahd Al-Mulla2, Jehad Abubaker1

  • 1Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, P.O. Box 1180, Dasman 15462, Kuwait.

Insights

The mammalian target of rapamycin (mTOR) pathway regulates cell functions and is crucial in diseases like cancer and diabetes. Developing dual-function mTOR inhibitors offers new therapeutic strategies for these conditions.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The mammalian target of rapamycin (mTOR) is a central regulator of cellular processes, integrating environmental signals.
  • Dysregulation of mTOR signaling is linked to metabolic disorders, cancer, cardiovascular diseases, and aging.
  • mTOR signaling pathways are complex and play a critical role in numerous physiological and pathological conditions.

Purpose of the Study:

  • To review the significance of mTOR signaling in human diseases.
  • To highlight key components of the mTOR network involved in disease pathogenesis.
  • To discuss recent advances in mTOR inhibitors and their clinical applications.

Main Methods:

  • Literature review of mTOR signaling pathways and inhibitors.
  • Analysis of the role of mTOR in disease development and progression.
  • Examination of current and emerging therapeutic strategies targeting mTOR.

Main Results:

  • mTOR signaling is implicated in protein synthesis, cell growth, survival, and apoptosis.
  • mTOR pathway dysregulation is a hallmark of diabetes, cardiovascular diseases, cancer, and aging.
  • mTOR inhibitors have shown therapeutic potential but require further development for enhanced efficacy.

Conclusions:

  • A comprehensive understanding of mTOR signaling is essential for developing effective treatments.
  • Next-generation mTOR inhibitors with dual functions are needed for efficient targeting of mTOR pathways.
  • Targeting mTOR offers a promising therapeutic avenue for a range of complex human diseases.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
9.9K